Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
API - Small Molecule
Sort By
Newest First
1 / 10
1 / 10
Liquid Suspensions
Beyond Pills: the Rise of Liquid Suspensions for Complex Formulations
Gus LaBella
Mikart
PAO-07-24-CL-04
July 09, 2024
Outsourced Manufacturing
A Closer Look at Small Molecule Drug Substance and Drug Product Manufacturing
April Stanley, MS MBA
PAO-03-24-NI-02
March 27, 2024
Nice Insight API Report
Small Molecule API Discovery and Development Trends
April Stanley, MS MBA
PAO-03-24-NI-01
March 21, 2024
Biomanufacturing
Antheia and Olon Continue Partnership for Biomanufacturing Antheia’s Pipeline of KSMs and APIs for Essential Medicines
Antheia
PR-M03-24-02
March 13, 2024
High Potency API Suite
Expanding Capabilities for Clients:Olon to Open New High Potency API Suite in US
Olon
PR-M02-24-01
February 05, 2024
Chromatography
Navigating HPLC Method Development: Tips for Success
Ransom Jones
Mikart
PAO-12-23-CL-09
January 17, 2024
Process Chemistry
Enabling Client Success with Complementary Services Built upon a Strong Chemistry Foundation
Jean-Francois Vincent-Rocan, Ph.D.
BIOVECTRA
PAO-12-23-CL-02
December 13, 2023
Is this Pharma’s Best Kept Secret? Partnering with Australian Companies for Pharmaceutical Development and Manufacturing
Grant Swart
Mayne Pharma Services
PAO-10-23-CL-04
October 18, 2023
Modified-Release Drug Formulations
Simplifying Modified-Release Drug Formulations with High-Quality Multiparticulate Cores
Donald Loveday, Ph.D.; Bill McCarthy; Doug Hovey
SPI Pharma
PAO-05-23-CL-06
June 06, 2023
Biocatalysis
Olon Presents the First Results Announcing to Have Achieved Developing A New Production Process Through Engineering Target Enzyme
Olon
PR-M05-23-02
May 10, 2023
API
Enhanced Solubility through API Processing: Salt and Cocrystal Formation
Thomas Briel, Ph.D.; David Luedeker, Ph.D.
MilliporeSigma
PAO-05-23-CL-04
May 05, 2023
HPAPIs
An Introduction to HPAPIs and Cytotoxic Drugs
Roots Analysis
PAO-04-23-CL-04
April 25, 2023
New R&D Center
Addition of New U.S. R&D Center is the Next Step in Asymchem’s Globalization Strategy
Peng Dai, Ph.D.; Steven Hu, Ph.D.
Asymchem
PAO-02-23-CL-07
March 09, 2023
Academic Research
Olon and The Chemistry Department of Politecnico University Launch a Research Project on Polymorphism and Characterization of API Solid State
Olon Group
PR-M02-23-02
February 21, 2023
Parenteral Drug Products
Innovating to Optimize Quality in Injectable Drugs
Michael Howell
Grifols
PAO-11-022-CL-16
January 12, 2023
Sustainable Manufacturing
Sustainability in Pharmaceutical Manufacturing: A CDMO’s Contribution
Mark McLaws, Ph.D.
Asymchem
PAO-11-022-CL-07
November 22, 2022
Olon, International API Supplier, Releases New 2022 Sustainability Report
Olon
PR-M11-22-08
November 22, 2022
Particle Engineering
Addressing Poor API Solubility with Comprehensive Particle Engineering Technology
Giorgio Bertolini, Ph.D.
Olon
PAO-11-022-CL-08
November 18, 2022
Taste Masking Formulations
Formulating Flexibility with ActiMask® Taste Masking
SPI Pharma
PAO-10-022-CL-05
October 25, 2022
High Containment
Olon, Leading International API Supplier, Announces A New Investment That Will Further Expand its Global High Containment Platform a New High Containment Line in the Site Located in India
Olon
PR-M09-22-06
September 27, 2022
